1
|
Collado-Pérez R, Jiménez-Hernaiz M, García-Piqueras J, Guerra-Cantera S, Argente J, Fernández-Marcos PJ, Frago LM, Chowen JA. LBODP109 Astrocytes Affect The Metabolism Of Proopiomelanocortin (pomc) Neurons Through The Release Of Exosomes That Are Modified In A Fatty Acid Specific Manner. J Endocr Soc 2022. [DOI: 10.1210/jendso/bvac150.006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
Abstract
Abstract
Astrocytes influence neighboring neurons through the release of a variety of signals, including exosomes, micro-vesicles that contain a vast heterogeneity of molecules such as cytokines, growth factors, RNAs and micro-RNAs (mi-RNAs) that modify target cells. We hypothesized that hypothalamic astrocytes communicate the metabolic status via exosomes to neighboring POMC neurons to modify their functions in the promotion of satiety and energy expenditure. To this end, primary hypothalamic astrocyte cultures were treated with palmitic acid (PA; 0.5 mM), oleic acid (OA; 0.5 mM) or vehicle for 24 hours and exosomes were isolated from the media and applied (1.25 or 2.50 µg/mL) to a POMC neuronal cell line for 24 hours. Exosomes released in response to PA (E-PA) or OA (E-OA) increased POMC expression (p < 0. 05) with no effect on the expression of markers of ER stress (CHOP) and inflammation [interleukin (IL)-6] compared to exosomes released from vehicle treated astrocytes (E-V) or with no exosomes (control). Seahorse Cell Mito Stress test was performed to determinate modifications in metabolism in the POMC neurons in response to these treatments. The mitochondrial spare respiratory capacity of neurons was increased (p < 0. 0001) in response to both doses of E-PA and E-OA, with the maximal respiration (p < 0. 0001) increasing with E-PA (both doses) or 2.50 µg/mL of E-OA compared to E-V or control. Next-generation miRNA sequencing analysis established the modifications of miRNAs contained in exosomes released by hypothalamic astrocytes in response to PA, with miR-199a-3p and miR-145-5p content being higher in E-PA compared to E-V. Transfection of POMC neurons with a mimetic of miR-199a-3p (1.5 pmol) increased POMC expression and insulin-like growth factor 1 receptor (IGF1r) protein levels (p<0. 05). Moreover, levels of mTOR as well as p70S6k, reported targets of miR-199a-3p, were decreased (both p<0. 05). Mimetic overexpression of miR-145-5p reduced POMC expression (p < 0. 001) and protein levels of insulin receptor substrate 1 (IRS1; p < 0. 001), which is a known target of this miRNA. These results suggest that astrocytes communicate with neurons via exosomes, with the exosomes content being modulated in response to the nutritional environment. The messages contained in astrocytic exosomes can directly alter the neuropeptide expression in targeted neurons as well as of the levels of receptors and factors involved in cell protection, metabolism, and nutrient sensing, with specific miRNAs participating in this process. Furthermore, cellular respiration of POMC neurons treated with fatty acid-modified astrocytic exosomes is modified in a manner that suggests they are preparing for a possible respiratory stress by increasing their spare respiratory capacity and maximal respiration.
Presentation: No date and time listed
Collapse
Affiliation(s)
- Roberto Collado-Pérez
- Hospital Infantil Universitario Niño Jesus, Universidad Autonoma de Madrid , Madrid , Spain
| | | | | | | | - Jesús Argente
- Hospital Infantil Universitario Niño Jesús, Universidad Autnoma de Madrid, CIBEROBN, IMDEA Food Institute , Madrid , Spain
| | | | - Laura M Frago
- Hospital Infantil Universitario Niño Jesús, Universidad Autonoma de Madrid , CIBEROBN, Madrid , Spain
| | - Julie A Chowen
- Hospital Infantil Universitario Niño Jesús, CIBEROBN, IMDEA Food Institute , Madrid , Spain
| |
Collapse
|
2
|
Fernández LP, Deleyto-Seldas N, Colmenarejo G, Sanz A, Wagner S, Plata-Gómez AB, Gómez-Patiño M, Molina S, Espinosa-Salinas I, Aguilar-Aguilar E, Ortega S, Graña-Castro O, Loria-Kohen V, Fernández-Marcos PJ, Efeyan A, Ramírez de Molina A. Folliculin-interacting protein FNIP2 impacts on overweight and obesity through a polymorphism in a conserved 3' untranslated region. Genome Biol 2022; 23:230. [PMID: 36316722 PMCID: PMC9620695 DOI: 10.1186/s13059-022-02798-5] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/29/2022] [Accepted: 10/19/2022] [Indexed: 11/04/2022] Open
Abstract
BACKGROUND Overweight and obesity are defined by an anomalous or excessive fat accumulation that may compromise health. To find single-nucleotide polymorphisms (SNPs) influencing metabolic phenotypes associated with the obesity state, we analyze multiple anthropometric and clinical parameters in a cohort of 790 healthy volunteers and study potential associations with 48 manually curated SNPs, in metabolic genes functionally associated with the mechanistic target of rapamycin (mTOR) pathway. RESULTS We identify and validate rs2291007 within a conserved region in the 3'UTR of folliculin-interacting protein FNIP2 that correlates with multiple leanness parameters. The T-to-C variant represents the major allele in Europeans and disrupts an ancestral target sequence of the miRNA miR-181b-5p, thus resulting in increased FNIP2 mRNA levels in cancer cell lines and in peripheral blood from carriers of the C allele. Because the miRNA binding site is conserved across vertebrates, we engineered the T-to-C substitution in the endogenous Fnip2 allele in mice. Primary cells derived from Fnip2 C/C mice show increased mRNA stability, and more importantly, Fnip2 C/C mice replicate the decreased adiposity and increased leanness observed in human volunteers. Finally, expression levels of FNIP2 in both human samples and mice negatively associate with leanness parameters, and moreover, are the most important contributor in a multifactorial model of body mass index prediction. CONCLUSIONS We propose that rs2291007 influences human leanness through an evolutionarily conserved modulation of FNIP2 mRNA levels.
Collapse
Affiliation(s)
- Lara P. Fernández
- grid.429045.e0000 0004 0500 5230Molecular Oncology Group, IMDEA Food Institute, CEI UAM + CSIC, Madrid, Spain
| | - Nerea Deleyto-Seldas
- grid.7719.80000 0000 8700 1153Spanish National Cancer Research Center, Madrid, Spain
| | - Gonzalo Colmenarejo
- grid.429045.e0000 0004 0500 5230Biostatistics and Bioinformatics Unit, IMDEA-Food Institute, CEI UAM+CSIC, Madrid, Spain
| | - Alba Sanz
- grid.7719.80000 0000 8700 1153Spanish National Cancer Research Center, Madrid, Spain
| | - Sonia Wagner
- grid.429045.e0000 0004 0500 5230Molecular Oncology Group, IMDEA Food Institute, CEI UAM + CSIC, Madrid, Spain
| | - Ana Belén Plata-Gómez
- grid.7719.80000 0000 8700 1153Spanish National Cancer Research Center, Madrid, Spain
| | - Mónica Gómez-Patiño
- grid.482878.90000 0004 0500 5302GENYAL Platform on Nutrition and Health, IMDEA Food Institute, CEI UAM + CSIC, Madrid, Spain
| | - Susana Molina
- grid.482878.90000 0004 0500 5302GENYAL Platform on Nutrition and Health, IMDEA Food Institute, CEI UAM + CSIC, Madrid, Spain
| | - Isabel Espinosa-Salinas
- grid.482878.90000 0004 0500 5302GENYAL Platform on Nutrition and Health, IMDEA Food Institute, CEI UAM + CSIC, Madrid, Spain
| | - Elena Aguilar-Aguilar
- grid.482878.90000 0004 0500 5302GENYAL Platform on Nutrition and Health, IMDEA Food Institute, CEI UAM + CSIC, Madrid, Spain
| | - Sagrario Ortega
- grid.7719.80000 0000 8700 1153Mouse Genome Editing Unit, Spanish National Cancer Research Center, Madrid, Spain
| | - Osvaldo Graña-Castro
- grid.7719.80000 0000 8700 1153Bioinformatics Unit, Spanish National Cancer Research Center, Madrid, Spain ,grid.8461.b0000 0001 2159 0415Institute of Applied Molecular Medicine (IMMA-Nemesio Díez), Department of Basic Medical Sciences, School of Medicine, San Pablo-CEU University, CEU Universities, Boadilla del Monte, Madrid, Spain
| | - Viviana Loria-Kohen
- grid.482878.90000 0004 0500 5302GENYAL Platform on Nutrition and Health, IMDEA Food Institute, CEI UAM + CSIC, Madrid, Spain
| | - Pablo J. Fernández-Marcos
- grid.429045.e0000 0004 0500 5230Metabolic Syndrome Group, IMDEA Food Institute, CEI UAM + CSIC, Madrid, Spain
| | - Alejo Efeyan
- grid.7719.80000 0000 8700 1153Spanish National Cancer Research Center, Madrid, Spain
| | - Ana Ramírez de Molina
- grid.429045.e0000 0004 0500 5230Molecular Oncology Group, IMDEA Food Institute, CEI UAM + CSIC, Madrid, Spain
| |
Collapse
|
3
|
Triana-Martínez F, Picallos-Rabina P, Da Silva-Álvarez S, Pietrocola F, Llanos S, Rodilla V, Soprano E, Pedrosa P, Ferreirós A, Barradas M, Hernández-González F, Lalinde M, Prats N, Bernadó C, González P, Gómez M, Ikonomopoulou MP, Fernández-Marcos PJ, García-Caballero T, Del Pino P, Arribas J, Vidal A, González-Barcia M, Serrano M, Loza MI, Domínguez E, Collado M. Author Correction: Identification and characterization of Cardiac Glycosides as senolytic compounds. Nat Commun 2020; 11:4771. [PMID: 32938939 PMCID: PMC7494855 DOI: 10.1038/s41467-020-18714-z] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022] Open
Abstract
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Collapse
Affiliation(s)
- Francisco Triana-Martínez
- Laboratory of Stem Cells in Cancer and Aging, Health Research Institute of Santiago de Compostela (IDIS), Xerencia de Xestión Integrada de Santiago (XXIS/SERGAS), E15706, Santiago de Compostela, Spain.,BioFarma, Center for Research in Molecular Medicine and Chronic Diseases (CIMUS), Universidade de Santiago de Compostela, Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain
| | - Pilar Picallos-Rabina
- Laboratory of Stem Cells in Cancer and Aging, Health Research Institute of Santiago de Compostela (IDIS), Xerencia de Xestión Integrada de Santiago (XXIS/SERGAS), E15706, Santiago de Compostela, Spain
| | - Sabela Da Silva-Álvarez
- Laboratory of Stem Cells in Cancer and Aging, Health Research Institute of Santiago de Compostela (IDIS), Xerencia de Xestión Integrada de Santiago (XXIS/SERGAS), E15706, Santiago de Compostela, Spain
| | - Federico Pietrocola
- Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), 08028, Barcelona, Spain
| | - Susana Llanos
- DNA Replication Group, Spanish National Cancer Research Centre (CNIO), 28029, Madrid, Spain
| | - Verónica Rodilla
- Preclinical Research Program, Vall d´Hebron Institute of Oncology (VHIO) and CIBERONC, Barcelona, Spain
| | - Enrica Soprano
- Centro Singular de Investigación en Química Biolóxica e Materiais Moleculares (CiQUS) and Departamento de Física de Partículas, Universidade de Santiago de Compostela, 15782, Santiago de Compostela, Spain
| | - Pablo Pedrosa
- Laboratory of Stem Cells in Cancer and Aging, Health Research Institute of Santiago de Compostela (IDIS), Xerencia de Xestión Integrada de Santiago (XXIS/SERGAS), E15706, Santiago de Compostela, Spain
| | - Alba Ferreirós
- Laboratory of Stem Cells in Cancer and Aging, Health Research Institute of Santiago de Compostela (IDIS), Xerencia de Xestión Integrada de Santiago (XXIS/SERGAS), E15706, Santiago de Compostela, Spain
| | - Marta Barradas
- Metabolic Syndrome Group, Madrid Institute for Advanced Studies (IMDEA) in Food, CEI UAM+CSIC, Madrid, E28049, Spain
| | - Fernanda Hernández-González
- Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), 08028, Barcelona, Spain.,Department of Pulmonology, ICR, Hospital Clinic, Instituto de Investigaciones Biomedicas August Pi i Sunyer (IDIBAPS), Barcelona, 08036, Spain
| | - Marta Lalinde
- Preclinical Research Program, Vall d´Hebron Institute of Oncology (VHIO) and CIBERONC, Barcelona, Spain
| | - Neus Prats
- Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), 08028, Barcelona, Spain
| | - Cristina Bernadó
- Preclinical Research Program, Vall d´Hebron Institute of Oncology (VHIO) and CIBERONC, Barcelona, Spain
| | - Patricia González
- Histopathology Unit, Spanish National Cancer Research Centre (CNIO), 28029, Madrid, Spain
| | - María Gómez
- Histopathology Unit, Spanish National Cancer Research Centre (CNIO), 28029, Madrid, Spain
| | - Maria P Ikonomopoulou
- Translational Venomics Group, Madrid Institute for Advanced Studies (IMDEA) in Food, CEI UAM+CSIC, Madrid, E28049, Spain
| | - Pablo J Fernández-Marcos
- Metabolic Syndrome Group, Madrid Institute for Advanced Studies (IMDEA) in Food, CEI UAM+CSIC, Madrid, E28049, Spain
| | - Tomás García-Caballero
- Departamento de Ciencias Morfológicas, Facultad de Medicina. USC. Xerencia de Xestión Integrada de Santiago (XXIS/SERGAS), E15706, Santiago de Compostela, Spain
| | - Pablo Del Pino
- Centro Singular de Investigación en Química Biolóxica e Materiais Moleculares (CiQUS) and Departamento de Física de Partículas, Universidade de Santiago de Compostela, 15782, Santiago de Compostela, Spain
| | - Joaquín Arribas
- Preclinical Research Program, Vall d´Hebron Institute of Oncology (VHIO) and CIBERONC, Barcelona, Spain.,Catalan Institution for Research and Advanced Studies (ICREA), 08010, Barcelona, Spain
| | - Anxo Vidal
- CiCLOn, Centro Singular de Investigación en Medicina Molecular y Enfermedades Crónicas (CIMUS), Universidade de Santiago de Compostela, Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), E15782, Santiago de Compostela, Spain
| | - Miguel González-Barcia
- Servicio de Farmacia, Xerencia de Xestión Integrada de Santiago (XXIS/SERGAS), E15706, Santiago de Compostela, Spain
| | - Manuel Serrano
- Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), 08028, Barcelona, Spain.,Catalan Institution for Research and Advanced Studies (ICREA), 08010, Barcelona, Spain
| | - María I Loza
- BioFarma, Center for Research in Molecular Medicine and Chronic Diseases (CIMUS), Universidade de Santiago de Compostela, Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain
| | - Eduardo Domínguez
- BioFarma, Center for Research in Molecular Medicine and Chronic Diseases (CIMUS), Universidade de Santiago de Compostela, Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain.
| | - Manuel Collado
- Laboratory of Stem Cells in Cancer and Aging, Health Research Institute of Santiago de Compostela (IDIS), Xerencia de Xestión Integrada de Santiago (XXIS/SERGAS), E15706, Santiago de Compostela, Spain.
| |
Collapse
|
4
|
Boutant M, Joffraud M, Kulkarni SS, García-Casarrubios E, García-Roves PM, Ratajczak J, Fernández-Marcos PJ, Valverde AM, Serrano M, Cantó C. SIRT1 enhances glucose tolerance by potentiating brown adipose tissue function. Mol Metab 2014; 4:118-31. [PMID: 25685699 PMCID: PMC4314542 DOI: 10.1016/j.molmet.2014.12.008] [Citation(s) in RCA: 66] [Impact Index Per Article: 6.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/03/2014] [Revised: 12/11/2014] [Accepted: 12/13/2014] [Indexed: 10/24/2022] Open
Abstract
OBJECTIVE SIRT1 has been proposed to be a key signaling node linking changes in energy metabolism to transcriptional adaptations. Although SIRT1 overexpression is protective against diverse metabolic complications, especially in response to high-fat diets, studies aiming to understand the etiology of such benefits are scarce. Here, we aimed to identify the key tissues and mechanisms implicated in the beneficial effects of SIRT1 on glucose homeostasis. METHODS We have used a mouse model of moderate SIRT1 overexpression, under the control of its natural promoter, to evaluate glucose homeostasis and thoroughly characterize how different tissues could influence insulin sensitivity. RESULTS Mice with moderate overexpression of SIRT1 exhibit better glucose tolerance and insulin sensitivity even on a low fat diet. Euglycemic-hyperinsulinemic clamps and in-depth tissue analyses revealed that enhanced insulin sensitivity was achieved through a higher brown adipose tissue activity and was fully reversed by housing the mice at thermoneutrality. SIRT1 did not influence brown adipocyte differentiation, but dramatically enhanced the metabolic transcriptional responses to β3-adrenergic stimuli in differentiated adipocytes. CONCLUSIONS Our work demonstrates that SIRT1 improves glucose homeostasis by enhancing BAT function. This is not consequent to an alteration in the brown adipocyte differentiation process, but as a result of potentiating the response to β3-adrenergic stimuli.
Collapse
Affiliation(s)
- Marie Boutant
- Nestlé Institute of Health Sciences (NIHS) SA, EPFL Campus, Quartier de l'Innovation, Bâtiment G, Lausanne CH-1015, Switzerland
| | - Magali Joffraud
- Nestlé Institute of Health Sciences (NIHS) SA, EPFL Campus, Quartier de l'Innovation, Bâtiment G, Lausanne CH-1015, Switzerland
| | - Sameer S Kulkarni
- Nestlé Institute of Health Sciences (NIHS) SA, EPFL Campus, Quartier de l'Innovation, Bâtiment G, Lausanne CH-1015, Switzerland
| | - Ester García-Casarrubios
- Instituto de Investigaciones Biomédicas Alberto Sols (CSIC-UAM), 28029 Madrid, Spain ; Spanish Biomedical Research Centre in Diabetes and Associated Metabolic Disorders (CIBERDEM), 28029 Madrid, Spain
| | - Pablo M García-Roves
- Spanish Biomedical Research Centre in Diabetes and Associated Metabolic Disorders (CIBERDEM), 28029 Madrid, Spain ; Diabetes and Obesity Research Laboratory, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona 08036, Spain
| | - Joanna Ratajczak
- Nestlé Institute of Health Sciences (NIHS) SA, EPFL Campus, Quartier de l'Innovation, Bâtiment G, Lausanne CH-1015, Switzerland ; Ecole Polytechnique Fédérale de Lausanne (EPFL), CH-1015 Lausanne, Switzerland
| | | | - Angela M Valverde
- Instituto de Investigaciones Biomédicas Alberto Sols (CSIC-UAM), 28029 Madrid, Spain ; Spanish Biomedical Research Centre in Diabetes and Associated Metabolic Disorders (CIBERDEM), 28029 Madrid, Spain
| | - Manuel Serrano
- Spanish National Cancer Research Center (CNIO), Madrid E28029, Spain
| | - Carles Cantó
- Nestlé Institute of Health Sciences (NIHS) SA, EPFL Campus, Quartier de l'Innovation, Bâtiment G, Lausanne CH-1015, Switzerland
| |
Collapse
|
5
|
Maraver A, Fernández-Marcos PJ, Herranz D, Muñoz-Martin M, Gomez-Lopez G, Cañamero M, Mulero F, Megías D, Sanchez-Carbayo M, Shen J, Sanchez-Cespedes M, Palomero T, Ferrando A, Serrano M. Therapeutic effect of γ-secretase inhibition in KrasG12V-driven non-small cell lung carcinoma by derepression of DUSP1 and inhibition of ERK. Cancer Cell 2012; 22:222-34. [PMID: 22897852 PMCID: PMC3813920 DOI: 10.1016/j.ccr.2012.06.014] [Citation(s) in RCA: 97] [Impact Index Per Article: 8.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/02/2011] [Revised: 02/02/2012] [Accepted: 06/19/2012] [Indexed: 02/05/2023]
Abstract
Here, we have investigated the role of the Notch pathway in the generation and maintenance of Kras(G12V)-driven non-small cell lung carcinomas (NSCLCs). We demonstrate by genetic means that γ-secretase and RBPJ are essential for the formation of NSCLCs. Of importance, pharmacologic treatment of mice carrying autochthonous NSCLCs with a γ-secretase inhibitor (GSI) blocks cancer growth. Treated carcinomas present reduced HES1 levels and reduced phosphorylated ERK without changes in phosphorylated MEK. Mechanistically, we show that HES1 directly binds to and represses the promoter of DUSP1, encoding a dual phosphatase that is active against phospho-ERK. Accordingly, GSI treatment upregulates DUSP1 and decreases phospho-ERK. These data provide proof of the in vivo therapeutic potential of GSIs in primary NSCLCs.
Collapse
Affiliation(s)
- Antonio Maraver
- Tumor Suppression Group, Spanish National Cancer Research Center (CNIO), Madrid, Spain
- Correspondence to:,
| | | | - Daniel Herranz
- Tumor Suppression Group, Spanish National Cancer Research Center (CNIO), Madrid, Spain
- Institute of Cancer Genetics, Columbia University Medical Center, New York, NY, USA
| | - Maribel Muñoz-Martin
- Tumor Suppression Group, Spanish National Cancer Research Center (CNIO), Madrid, Spain
| | - Gonzalo Gomez-Lopez
- Bioinformatics Unit, Spanish National Cancer Research Center (CNIO), Madrid, Spain
| | - Marta Cañamero
- Comparative Pathology Unit, Spanish National Cancer Research Center (CNIO), Madrid, Spain
| | - Francisca Mulero
- Molecular Imaging Unit, Spanish National Cancer Research Center (CNIO), Madrid, Spain
| | - Diego Megías
- Confocal Microscopy Unit, Spanish National Cancer Research Center (CNIO), Madrid, Spain
| | | | - Jie Shen
- Center for Neurologic Diseases, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, USA
| | | | - Teresa Palomero
- Institute of Cancer Genetics, Columbia University Medical Center, New York, NY, USA
| | - Adolfo Ferrando
- Institute of Cancer Genetics, Columbia University Medical Center, New York, NY, USA
| | - Manuel Serrano
- Tumor Suppression Group, Spanish National Cancer Research Center (CNIO), Madrid, Spain
- Correspondence to:,
| |
Collapse
|
6
|
Tomás-Loba A, Flores I, Fernández-Marcos PJ, Cayuela ML, Maraver A, Tejera A, Borrás C, Matheu A, Klatt P, Flores JM, Viña J, Serrano M, Blasco MA. Telomerase reverse transcriptase delays aging in cancer-resistant mice. Cell 2008; 135:609-22. [PMID: 19013273 DOI: 10.1016/j.cell.2008.09.034] [Citation(s) in RCA: 295] [Impact Index Per Article: 18.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/15/2008] [Revised: 06/18/2008] [Accepted: 09/15/2008] [Indexed: 12/28/2022]
Abstract
Telomerase confers limitless proliferative potential to most human cells through its ability to elongate telomeres, the natural ends of chromosomes, which otherwise would undergo progressive attrition and eventually compromise cell viability. However, the role of telomerase in organismal aging has remained unaddressed, in part because of the cancer-promoting activity of telomerase. To circumvent this problem, we have constitutively expressed telomerase reverse transcriptase (TERT), one of the components of telomerase, in mice engineered to be cancer resistant by means of enhanced expression of the tumor suppressors p53, p16, and p19ARF. In this context, TERT overexpression improves the fitness of epithelial barriers, particularly the skin and the intestine, and produces a systemic delay in aging accompanied by extension of the median life span. These results demonstrate that constitutive expression of Tert provides antiaging activity in the context of a mammalian organism.
Collapse
Affiliation(s)
- Antonia Tomás-Loba
- Telomeres and Telomerase Group, Molecular Oncology Program, Spanish National Cancer Centre CNIO, Madrid, Spain
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|